Technical Director, R&D
AbbottFull Time
Expert & Leadership (9+ years)
Founded in 2022, Apogee Therapeutics, Inc. is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally.
Apogee Therapeutics, Inc. is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and other inflammatory and immunology indications with high unmet need. Our antibody programs are designed to potentially overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. We seek to reshape the current standard of care for inflammatory and immune diseases because we believe people living with these diseases deserve the best possible treatment, and we refuse to stop at “good enough.”
We are a fast-paced company committed to building an exceptional company culture, founded on our C.O.R.E. values: Caring, Original, Resilient and Egoless.
If this sounds like you, keep reading!
We are seeking an R&D System Analyst to join our growing IT Enterprise Applications team. This role will directly support R&D functions (including Clinical Operations, Clinical Development, Quality, Regulatory, and Biometrics) by driving system/business process optimization, managing system change controls, and supporting computer system validation (CSV) activities in a GxP-regulated environment. This role is centered around applications and tools used to oversee and document clinical trials, as well as the processes to collate and submit to health authority agency(s).
This role will serve as a key partner to both IT and R&D business stakeholders, ensuring our enterprise applications meet operational needs and regulatory requirements. This position reports to the Associate Director, GxP R&D Systems within the IT Enterprise Applications team and plays a critical role in the lifecycle management of R&D systems such as Veeva Vault and other cloud-based applications.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.